Sunbound Raises $24M Series A and Acquires Richter Healthcare Consultants
Sunbound's $24M Series A and Richter acquisition combine care-sector financial software with services. The undisclosed purchase price is separate from the funding.
Explore our latest articles on healthcare — covering venture capital deals, fund activity, startup fundraising strategy, and investor research relevant to this topic.
Whether you're a founder building an investor target list, an analyst tracking deal flow, or an operator researching market trends, the articles below provide practical, up-to-date venture capital intelligence.
Browse all healthcare articles below, or use our investor list to research active investors by stage and sector.
Sunbound's $24M Series A and Richter acquisition combine care-sector financial software with services. The undisclosed purchase price is separate from the funding.
Transformation Capital leads Abby Care's reported $82M Series C. The company confirms the close as it expands clinically supported, paid family caregiving.
OrbiMed raised about $3B across Private Investments X and Asia Partners VI. The separate mandates matter more than one combined fundraising headline.
Sava Technologies raised a $36 million Series B led by Ascensia Diabetes Care and paired it with a European distribution agreement for its glucose microsensor.
Zeal Capital Partners led an $8M Series A in Rising Team and backed Seven Starling’s $8M maternal-health round, deploying its new Fund II.
Spark Capital led Latent Health’s $80M Series A at a $600M valuation, continuing an active run of AI and healthcare leads.
Notation Capital backed Photon Health’s $16M Series A, a follow-on to its earlier lead, staying true to its NYC pre-seed roots.
New Enterprise Associates led Qualified Health’s $125M Series B for enterprise healthcare AI, part of a broad 2026 AI push spanning Twelve Labs and Corca.
LifeMine raised an oversubscribed $188M Series E (plus a prior $75M Series D) to push LIFE-001 — a novel calcineurin-pathway immunosuppressant — toward Phase 2 kidney transplant studies, with ARCH among continuing backers.
General Atlantic led Expedition’s oversubscribed $115M Series B as the biotech dosed the first patient in a global Phase 2 COPD trial of EXPD-101 — a China-sourced NewCo twist.
Eniac Ventures backed Kin Health’s seed round, its latest 2026 deal as the seed firm concentrates on applied AI, healthcare, and infrastructure.
Cowboy Ventures joined Basata’s $21M Series A to automate healthcare operations, part of a busy 2026 that also included leading Petual’s seed round.